BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 15609302)

  • 21. Head and neck in situ carcinoma: survival analysis of the Thuringian cancer registration database.
    Guntinas-Lichius O; Wendt T; Buentzel J; Esser D; Lochner P; Mueller A; Schultze-Mosgau S; Altendorf-Hofmann A;
    Oral Oncol; 2010 Apr; 46(4):e5-9. PubMed ID: 20227329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A population-based study of therapy and survival for patients with head and neck cancer treated in the community.
    Dansky Ullmann C; Harlan LC; Shavers VL; Stevens JL
    Cancer; 2012 Sep; 118(18):4452-61. PubMed ID: 22252676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-year survival rates and time trends of laryngeal cancer in the US population.
    Cosetti M; Yu GP; Schantz SP
    Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of Suicide in Patients With Head and Neck Cancer.
    Kam D; Salib A; Gorgy G; Patel TD; Carniol ET; Eloy JA; Baredes S; Park RC
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1075-81. PubMed ID: 26562764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015.
    Brouwer AF; He K; Chinn SB; Mondul AM; Chapman CH; Ryser MD; Banerjee M; Eisenberg MC; Meza R; Taylor JMG
    Cancer; 2020 Dec; 126(23):5137-5146. PubMed ID: 32888317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head and neck cancer in Canada: trends 1992 to 2007.
    Johnson-Obaseki S; McDonald JT; Corsten M; Rourke R
    Otolaryngol Head Neck Surg; 2012 Jul; 147(1):74-8. PubMed ID: 22328702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric head and neck tumors: an intra-demographic analysis using the SEER* database.
    Cesmebasi A; Gabriel A; Niku D; Bukala K; Donnelly J; Fields PJ; Tubbs RS; Loukas M
    Med Sci Monit; 2014 Dec; 20():2536-42. PubMed ID: 25473782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Head and neck in situ carcinoma: incidence, trends, and survival.
    Reid BC; Winn DM; Morse DE; Pendrys DG
    Oral Oncol; 2000 Sep; 36(5):414-20. PubMed ID: 10964047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in presentation and survival of head and neck carcinomas in Northeastern Italy, 1975-1998.
    Barzan L; Talamini R; Franchin G; Vaccher E; Politi D; Minatel E; Gobitti C
    Cancer; 2002 Aug; 95(3):540-52. PubMed ID: 12209746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
    Smith VA; Camp ER; Lentsch EJ
    Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric head and neck squamous cell carcinoma: Patient demographics, treatment trends and outcomes.
    Modh A; Gayar OH; Elshaikh MA; Paulino AC; Siddiqui F
    Int J Pediatr Otorhinolaryngol; 2018 Mar; 106():21-25. PubMed ID: 29447885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and survival patterns of cranial chordoma in the United States.
    Chambers KJ; Lin DT; Meier J; Remenschneider A; Herr M; Gray ST
    Laryngoscope; 2014 May; 124(5):1097-102. PubMed ID: 24122844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent changes in the epidemiology of head and neck cancer.
    Curado MP; Hashibe M
    Curr Opin Oncol; 2009 May; 21(3):194-200. PubMed ID: 19363341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spindle cell carcinoma of the upper aerodigestive tract: an analysis of 341 cases with comparison to conventional squamous cell carcinoma.
    Gerry D; Fritsch VA; Lentsch EJ
    Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):576-83. PubMed ID: 24634155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant head and neck paragangliomas: treatment efficacy and prognostic indicators.
    Sethi RV; Sethi RK; Herr MW; Deschler DG
    Am J Otolaryngol; 2013; 34(5):431-8. PubMed ID: 23642313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in incidence of head and neck cancers in India.
    Yeole BB
    Asian Pac J Cancer Prev; 2007; 8(4):607-12. PubMed ID: 18260738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant fibrous histiocytoma: Database review suggests a favorable prognosis in the head and neck.
    Borucki RB; Neskey DM; Lentsch EJ
    Laryngoscope; 2018 Apr; 128(4):885-888. PubMed ID: 28988458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.